Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment
Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment
Antimicrob. agents chemother; 58 (6), 2014
This is a substudy of the Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS) Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146-CARINEMO) trial, which assessed the pharmacokinetics of rifampin or isoniazid with or without the coadm...
HIV/efeitos dos fármacos, Antituberculosos/administração & dosagem, Benzoxazinas, Mycobacterium, Mycobacterium tuberculosis/efeitos dos fármacos, Tuberculose/tratamento farmacológico, Síndrome da Imunodeficiência Adquirida/epidemiologia, Soroprevalência de HIV/tendências, Hepatite/diagnóstico, Antígenos CD4/efeitos dos fármacos, Moçambique/epidemiologia